A simple probabilistic multiplier model estimating the societal and healthcare burdens of SARS-CoV-2 infections indicated that 2.4 million hospitalizations, 44.8 million symptomatic illnesses, and 52.9 million total infections may have occurred in the U.S. during February 27\u2013September 30, 2020. Laboratory-confirmed infections that were reported were adjusted for potential under-detection based on testing practices and assay sensitivity. The authors estimated that through the end of September, only 1 of every 2.5 hospitalized infections and 1 of every 7.1 non-hospitalized illnesses may have been reported. They adjusted for potential under-detection by applying testing practices and assay sensitivity multipliers to the number of laboratory-confirmed reported infections.<\/p>\n
Reese et al. (Nov 25, 2020). Estimated Incidence of COVID-19 Illness and Hospitalization \u2014 United States, February\u2013September, 2020. Clinical Infectious Diseases. <\/i>https:\/\/doi.org\/10.1093\/cid\/ciaa1780<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" A simple probabilistic multiplier model estimating the societal and healthcare burdens of SARS-CoV-2 infections indicated that 2.4 million hospitalizations, 44.8 million symptomatic illnesses, and 52.9 million total infections may have occurred in the U.S. during February 27\u2013September 30, 2020. Laboratory-confirmed infections that were reported were adjusted for potential under-detection based on testing practices and assay…<\/p>\n